Literature DB >> 8490481

Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society.

P Sever1, G Beevers, C Bulpitt, A Lever, L Ramsay, J Reid, J Swales.   

Abstract

Several important new issues have arisen in the management of patients with hypertension. A working party of the British Hypertension Society has therefore reviewed available intervention studies on anti-hypertensive treatment and made recommendations on blood pressure thresholds for intervention, on non-pharmacological and pharmacological treatments, and on treatment goals. This report also provides guidelines on blood pressure measurement, essential investigations, referrals for specialist advice, follow up, and stopping treatment.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8490481      PMCID: PMC1677457          DOI: 10.1136/bmj.306.6883.983

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  12 in total

1.  THE ROLE OF BLOOD-PRESSURE CONTROL IN PREVENTING COMPLICATIONS OF HYPERTENSION.

Authors:  M HAMILTON; E M THOMPSON; T K WISNIEWSKI
Journal:  Lancet       Date:  1964-02-01       Impact factor: 79.321

Review 2.  How far should blood pressure be lowered?

Authors:  A E Fletcher; C J Bulpitt
Journal:  N Engl J Med       Date:  1992-01-23       Impact factor: 91.245

3.  Recommendations on blood pressure measurement.

Authors:  J C Petrie; E T O'Brien; W A Littler; M de Swiet
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-06

4.  Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

Authors:  B Dahlöf; L H Lindholm; L Hansson; B Scherstén; T Ekbom; P O Wester
Journal:  Lancet       Date:  1991-11-23       Impact factor: 79.321

Review 5.  Can ambulatory blood pressure monitoring improve the diagnosis of mild hypertension?

Authors:  T G Pickering
Journal:  J Hypertens Suppl       Date:  1990-12

6.  Benefits and potential harm of lowering high blood pressure.

Authors:  J M Cruickshank; J M Thorp; F J Zacharias
Journal:  Lancet       Date:  1987-03-14       Impact factor: 79.321

7.  Coronary flow reserve and the J curve relation between diastolic blood pressure and myocardial infarction.

Authors:  J M Cruickshank
Journal:  BMJ       Date:  1988-11-12

8.  Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease.

Authors:  J Stamler; J D Neaton; D N Wentworth
Journal:  Hypertension       Date:  1989-05       Impact factor: 10.190

Review 9.  Treating mild hypertension. Report of the British Hypertension Society working party.

Authors: 
Journal:  BMJ       Date:  1989-03-18

10.  Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias.

Authors:  S MacMahon; R Peto; J Cutler; R Collins; P Sorlie; J Neaton; R Abbott; J Godwin; A Dyer; J Stamler
Journal:  Lancet       Date:  1990-03-31       Impact factor: 79.321

View more
  85 in total

1.  The prevalence and incidence of medical conditions in healthy pharmaceutical company employees who volunteer to participate in medical research.

Authors:  S D Singh; A J Williams
Journal:  Br J Clin Pharmacol       Date:  1999-07       Impact factor: 4.335

Review 2.  Renal artery stenosis as a cause of renal impairment: implications for treatment of hypertension and congestive heart failure.

Authors:  J E Scoble
Journal:  J R Soc Med       Date:  1999-10       Impact factor: 5.344

3.  Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association.

Authors: 
Journal:  Heart       Date:  1998-12       Impact factor: 5.994

Review 4.  Noncompliance with antihypertensive therapy. Economic consequences.

Authors:  T L Skaer; D A Sclar; L M Robison
Journal:  Pharmacoeconomics       Date:  1996-01       Impact factor: 4.981

Review 5.  Clinical guidelines: proliferation and medicolegal significance.

Authors:  B Hurwitz
Journal:  Qual Health Care       Date:  1994-03

6.  Oversight: a retrospective study of biochemical monitoring in patients beginning antihypertensive drug treatment in primary care.

Authors:  Jamie J Coleman; Sarah E McDowell; Stephen J W Evans; Paramjit S Gill; Robin E Ferner
Journal:  Br J Clin Pharmacol       Date:  2010-07       Impact factor: 4.335

7.  Patients' own assessments of quality of primary care compared with objective records based measures of technical quality of care: cross sectional study.

Authors:  Mala Rao; Aileen Clarke; Colin Sanderson; Richard Hammersley
Journal:  BMJ       Date:  2006-06-22

Review 8.  Drug treatment of hypertension complicating diabetes mellitus.

Authors:  M J MacLeod; J McLay
Journal:  Drugs       Date:  1998-08       Impact factor: 9.546

Review 9.  The Hypertension in the Very Elderly Trial (HYVET). Rationale, methodology and comparison with previous trials.

Authors:  C J Bulpitt; A E Fletcher; A Amery; J Coope; J G Evans; S Lightowlers; K O'Malley; A Palmer; J Potter; P Sever
Journal:  Drugs Aging       Date:  1994-09       Impact factor: 3.923

10.  Diabetes mellitus and raised serum triglyceride concentration in treated hypertension--are they of prognostic importance? Observational study.

Authors:  O Samuelsson; K Pennert; O Andersson; G Berglund; T Hedner; B Persson; H Wedel; L Wilhelmsen
Journal:  BMJ       Date:  1996-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.